Alternatively, a recent paper on bioinformatics analysis of public microarray data identified Retsat as a key component in disorders relating to insulin resistance in both mice and humans [31], a condition strongly associated to NAFLD. Here, RETSAT is linked to metabolic dysfunction-associated steatotic liver disease.